Skip to main content

and
  1. No Access

    Article

    Asparagine bioavailability regulates the translation of MYC oncogene

    Amino acid restriction has recently emerged as a compelling strategy to inhibit tumor growth. Recent work suggests that amino acids can regulate cellular signaling in addition to their role as biosynthetic sub...

    Sankalp Srivastava, Jie Jiang, Jagannath Misra, Gretchen Seim, Kirk A. Staschke in Oncogene (2022)

  2. No Access

    Article

    Adapting to cell stress from inside and out

    The ability of cancer cells to adapt to external and internal stresses is critical for tumourigenesis. A new study now shows that the integrated stress response is critical for tumour cell adaptation to stress...

    Kirk A. Staschke, Ronald C. Wek in Nature Cell Biology (2019)

  3. Article

    Open Access

    Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells

    Oxidative stress determines cell fate through several mechanisms, among which regulation of mRNA translation by the phosphorylation of the alpha (α) subunit of the translation initiation factor eIF2α at serine...

    Jothilatha Krishnamoorthy, Clara Tenkerian, Jyotsana Gupta in Cell Death & Disease (2018)

  4. No Access

    Chapter

    7 Regulation of the yeast general amino acid control pathway in response to nutrient stress

    In response to starvation for amino acids, yeast cells induce the expression of a collection of genes involved in amino acid metabolism. This pathway referred to as the general amino acid control is a true cro...

    Ronald C. Wek, Kirk A. Staschke in Nutrient-Induced Responses in Eukaryotic C… (2004)

  5. No Access

    Book

    Antiviral Agents

    Advances and Problems

    Dr. E. Jucker in Progress in Drug Research (2001)

  6. No Access

    Chapter

    Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection

    A safe and effective vaccine for hepatitis B virus (HBV) has been available for nearly twenty years and currently campaigns to provide universal vaccination in develo** countries are underway. Nevertheless, ...

    Kirk A. Staschke, Joseph M. Colacino in Antiviral Agents (2001)

  7. No Access

    Book

  8. No Access

    Chapter

    The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection

    Hepatitis B virus (HBV) is the leading cause of chronic hepatitis throughout the world. Notwithstanding the availability of a safe and effective vaccine, the world prevalence of HBV has not declined significan...

    Joseph M. Colacino, Kirk A. Staschke in Progress in Drug Research (1998)